4//SEC Filing
LUNDBERG MAGNUS 4
Accession 0001179110-13-006442
CIK 0001012140other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:52 PM ET
Size
7.8 KB
Accession
0001179110-13-006442
Insider Transaction Report
Form 4
LUNDBERG MAGNUS
Director
Transactions
- Sale
Common Stock
2013-04-01$92.00/sh−10,000$920,000→ 14,216 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-04-01−10,000→ 0 totalExercise: $23.70From: 2006-06-08Exp: 2015-06-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-04-01$23.70/sh+10,000$237,000→ 24,216 total
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeother
Related Parties
1- filerCIK 0001235944
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:52 PM ET
- Size
- 7.8 KB